Nadine Beetz
2PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Oct 07, 2024
A randomized phase I study of BI 1820237, a novel neuropeptide Y receptor type 2 agonist, alone or in combination with low-dose liraglutide in otherwise healthy men with overweight or obesity.Nadine Beetz, Brigitte Kalsch, Thomas Forst
|May 06, 2020
Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes.Ildiko Lingvay, Nadine Beetz, Regina Sennewald
Pageof 1
